Group items matching

in title, tags, annotations or url

Amgen Inc sued Novartis AG's Sandoz in a federal court in the United States on Monday (May 1), accusing Sandoz's proposed versions of its multibillion-dollar bone-strengthening drugs Prolia and Xgeva of infringing several patents. Amgen asked the New Jersey court to block Sandoz's biosimilars of the drugs until its patents expire. One of the patents named in the complaint does not expire until 2037. Sandoz declined to comment on the lawsuit on Tuesday. Novartis, which is also named in the complaint, is preparing to spin Sandoz off into a standalone company later this year. Amgen's Prolia is used to treat osteoporosis. Xgeva, with the same active ingredient denosumab, treats bone cancer and prevents fractures in bone-cancer patients.

Metabolic Syndrome: Risk, Diagnosis, and Treatment is organized by Wild Iris Medical Education, Inc, and will be held from July 19, 2022, to November 01, 2023

108: Breast Cancer (N) is organized by Medical Education Systems (MedEdSys), Inc. Outline the meaning of and implications of Breast Cancer

Sleep Disorders (N) is organized by Medical Education Systems (MedEdSys), Inc and will be held from May 1, 2022, to May 31, 2023

Module 1 - Understanding the clinical value of genes and molecules identified in the mechanism of disease is organized by Persona Biomed, Inc

311: Idiopathic Pulmonary Fibrosis (N) is organized by Medical Education Systems (MedEdSys), Inc. Identify how idiopathic pulmonary fibrosis is diagnosed

AMS 2023: Pediatric Infectious Diseases: A Primary Care and Hospitalist Approach is organized by American Medical Seminars, Inc. and will be held from May 08 - 11, 2023 in Florida

AMS 2024: IMpu-Internal Medicine- Pulmonary online CME course is organized by American Medical Seminars, Inc. This conference has been approved for a maximum of 5 AMA PRA Category 1 Credits.

AMS Hospital And Internal Medicine CME Conference is organized by American Medical Seminars, Inc. and will be held from Jan 22 - 25, 2024 in Sarasota.

Kentucky Physicians State Board required Courses and Emergency Medicine & Pediatric Emergency Medicine Courses Bundle is organized by eMedEd, Inc. and will be held from Apr 04, 2022 - Aug 30, 2024. It encompasses a total of sixteen courses, addressing one mandatory topics specified by the Kentucky Physicians State Board and twelve courses specifically relevant to their respective specialties.

GlaxoSmithKline on Tuesday (May 31) snapped up US biopharmaceutical firm Affinivax for up to $3.3 billion, expanding further into vaccines before the demerger of its consumer health care arm. The London-listed company has agreed to pay $2.1 billion upfront and up to $1.2 billion in potential development milestones for Affinivax. "GSK plc today announced that it has entered into a definitive agreement to acquire Affinivax, Inc," it said in a statement. "Affinivax is pioneering the development of a novel class of vaccines, the most advanced of which are next-generation pneumococcal vaccines," it added. The Cambridge, Massachusetts-based firm specialises in vaccines for diseases including meningitis, pneumonia and bloodstream infections. "The proposed acquisition further strengthens our vaccines research and development (R&D) pipeline, provides access to a new, potentially disruptive technology, and broadens GSK's existing scientific footprint in the Boston area," said GSK's chief scientific officer Hal Barron.

Britain's billionaire Issa brothers and Indian tycoon Mukesh Ambani are preparing to face off in the final battle for Boots UK ownership, according to Bloomberg. In the first round, Issa brothers have submitted the highest offer, the people with knowledge of the matter told Bloomberg. "The brothers are going up against Ambani, who's been working on a bid together with buyout firm Apollo Global Management Inc." The source said: "Bidders are now sizing up Boots' billions in pension guarantees - which they'll have to take on - as they figure out how much they can pay for the business." They're also working around the clock to arrange financing in a difficult market, which has gotten that much tougher due to the war in Ukraine, soaring inflation and rising interest rates, according to the people.

AMS 2023: Cardiac Emergencies: Catastrophes on the Floor is organized by American Medical Seminars, Inc. and will be held from Apr 24 - 27, 2023

Liver Disease and the Older Patient is organized by eMedEd. Inc and will be held from Mar 28, 2022 - Mar 28, 2024.

AMS 2023: Infectious Disease Treatment in Both Outpatient and Inpatient Settings is organized by American Medical Seminars, Inc. and will be held from Mar 20 - 23, 2023 in Florida.

Amgen Inc on Monday agreed to buy Horizon Therapeutics Plc in a deal valued at $27.8 billion (£22.67bn), fortifying its rare diseases portfolio in the biggest buyout in the sector this year. The company will pay $116.50 in cash, a premium of nearly 20 per cent to the stock's last close, for each Horizon share. Horizon shares closed up 15 per cent on Monday at $112.36. They had climbed 23.5 per cent through Friday since the company disclosed in late November it was in preliminary talks with Amgen, Sanofi and Johnson & Johnson for potential offers. Amgen shares dipped less than 1 per cent to close at $276.78. Sanofi said Sunday it ended discussions with Horizon after concluding the transaction prices "do not meet our value criteria." J&J also said in early December that it had dropped its pursuit of the deal.

118: Guillain-Barre Syndrome (N) is organized by Medical Education Systems (MedEdSys), Inc. Identify the prognosis of persons with Guillain-Barr& eacute; syndrome

Diabetes Type 2: Prevention, Symptoms, and Treatment 2022 is organized by Wild Iris Medical Education, Inc. Review the underlying causes of diabetes.

Cultural Competency and Implicit Bias Training: Caring for LGBTQ+ Patients is organized by Wild Iris Medical Education, Inc.

AMS 2024: Internal Medicine A Review And Update-Rheumatology, Endocrinology, And Cardiology is organized by American Medical Seminars, Inc. and will be held from May 20 - 23, 2024. Clinical approach to rheumatology (Wasko) Diagnostic testing in rheumatic diseases (Wasko) Thyroid Case Studies (Winters, S) Polycystic Ovary Syndrome (Winters, S) Hypo and Hypercalcemia (Winters, S)